Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression
- PMID: 27400276
- DOI: 10.1159/000446502
Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the death of motor neurones, which leads to paralysis and death in an average of 3 years following diagnosis. The cause of ALS is unknown, but there is substantial evidence that metabolic factors, including nutritional state and body weight, affect disease progression and survival. This review provides an overview of the characteristics of metabolic dysregulation in ALS focusing on mechanisms that lead to disrupted energy supply (at a whole-body and cellular level) and altered energy expenditure. We discuss how a decrease in energy supply occurs in parallel with an increase in energy demand and leads to a state of chronic energy deficit which has a negative impact on disease outcome in ALS. We conclude by presenting potential and tested strategies to compensate for, or correct this energy imbalance, and speculate on promising areas for further research.
© 2016 S. Karger AG, Basel.
Similar articles
-
AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis.Neurochem Res. 2016 Mar;41(3):544-53. doi: 10.1007/s11064-015-1665-3. Epub 2015 Jul 23. Neurochem Res. 2016. PMID: 26202426 Review.
-
The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice.Biomed Pharmacother. 2005 May;59(4):190-6. doi: 10.1016/j.biopha.2005.03.003. Epub 2005 Mar 17. Biomed Pharmacother. 2005. PMID: 15862714
-
Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis.Expert Rev Mol Med. 2017 Jun 9;19:e7. doi: 10.1017/erm.2017.9. Expert Rev Mol Med. 2017. PMID: 28597807 Review.
-
Nutritional and metabolic factors in amyotrophic lateral sclerosis.Nat Rev Neurol. 2023 Sep;19(9):511-524. doi: 10.1038/s41582-023-00845-8. Epub 2023 Jul 27. Nat Rev Neurol. 2023. PMID: 37500993 Review.
-
Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis.Neurobiol Aging. 2014 Jun;35(6):1499-509. doi: 10.1016/j.neurobiolaging.2013.11.025. Epub 2013 Dec 3. Neurobiol Aging. 2014. PMID: 24439480
Cited by
-
Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study.PLoS One. 2021 May 6;16(5):e0251087. doi: 10.1371/journal.pone.0251087. eCollection 2021. PLoS One. 2021. PMID: 33956876 Free PMC article.
-
Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis.Metabolites. 2022 Jul 29;12(8):709. doi: 10.3390/metabo12080709. Metabolites. 2022. PMID: 36005581 Free PMC article. Review.
-
The Peripheral Immune System and Amyotrophic Lateral Sclerosis.Front Neurol. 2020 Apr 21;11:279. doi: 10.3389/fneur.2020.00279. eCollection 2020. Front Neurol. 2020. PMID: 32373052 Free PMC article. Review.
-
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?Cell Biosci. 2021 Jan 11;11(1):14. doi: 10.1186/s13578-020-00511-2. Cell Biosci. 2021. PMID: 33431046 Free PMC article. Review.
-
Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis.Eur J Neurol. 2023 Jan;30(1):57-68. doi: 10.1111/ene.15589. Epub 2022 Nov 8. Eur J Neurol. 2023. PMID: 36214080 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous